Nemati and colleagues assessed whether the genes involved in response to topotecan-based chemotherapy in a panel of human SCLC xenografts could be useful for guiding future clinical assessment.

Radiopharm Theranostic (RADX)s announced a poster presentation at EMIM 20251, with findings that support the clinical utility of imaging and ...

The resulting CD19-CAR T-cells were specifically activated by CD19-positive tumor cell lines and primary chronic lymphocytic leukemia cells, and eliminated human lymphoma xenografts in ...